Antonio Passaro/X
May 26, 2025, 10:33
Antonio Passaro: IEO Announces Public “Di Martedì” Event on Clinical Research in Oncogene-Addicted NSCLC
Antonio Passaro, Medical Oncologist and a Medical Director with High Specialization Assignment at the European Institute of Oncology, shared a post on LinkedIn:
“The next episode of ‘Di Martedì’ will not be an appointment like the others.
On Tuesday, May 27, from 3:30 pm to 5:30 pm, we look forward to seeing you for a special episode, open to the public: a unique moment to talk together about clinical research, experimental studies and future prospects for patients with oncogene-addicted non-small cell lung cancer (NSCLC).
An initiative designed not only for medical colleagues, but also for all professionals in the pharmaceutical sector, researchers, and above all for patients and their families, the real protagonists of the research to which we dedicate our work.
We will talk about how clinical trials are born and developed, the many clinical trials open at our IEO Thoracic Oncology Division, and above all what it means for a patient to enter an experimental study.
Questions, doubts, curiosities: there will be room for everyone. Just click here to participate.
We are waiting for you. Because research is done together, and we Cura better where we do Ricerca!”
IEO announced a special open-to-the-public episode of “Di Martedì” scheduled for May 27. The session will explore clinical trials for oncogene-addicted non-small cell lung cancer, highlighting ongoing studies and the patient experience in experimental research.
More posts featuring Antonio Passaro.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 8, 2025, 17:03
Jun 8, 2025, 16:53